Carlsmed Ord Shs
CARL12.700USD
-0.240-1.85%
Close 12/10, 16:00（ET）Quotes delayed by 15 min
337.62MMarket Cap
--P/E TTM
More Details of Company
Carlsmed Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Carlsmed Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
--
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
--
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
--
Mr. Robert E. Mittendorff, M.D.
Mr. Robert E. Mittendorff, M.D.
Independent Director
Independent Director
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Kevin K. Sidow
Mr. Kevin K. Sidow
Independent Director
Independent Director
--
--
Mr. Leonard (Leo) Greenstein
Mr. Leonard (Leo) Greenstein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Philip (Phil) Young
Mr. Philip (Phil) Young
Independent Director
Independent Director
--
--
Ms. Jenifer Kamocsay
Ms. Jenifer Kamocsay
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
--
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
--
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
--
Mr. Robert E. Mittendorff, M.D.
Mr. Robert E. Mittendorff, M.D.
Independent Director
Independent Director
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 23 hours ago
Updated: 23 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
Other
34.01%
Shareholders
Shareholders
Proportion
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
Other
34.01%
Shareholder Types
Shareholders
Proportion
Corporation
31.29%
Venture Capital
21.22%
Individual Investor
11.54%
Investment Advisor/Hedge Fund
5.36%
Private Equity
4.71%
Investment Advisor
4.03%
Hedge Fund
2.55%
Pension Fund
0.67%
Research Firm
0.14%
Other
18.49%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
68
10.32M
38.80%
+9.31M
2025Q3
68
10.32M
38.80%
+9.32M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
B Capital Group Management LP
8.32M
31.29%
--
--
Sep 30, 2025
U.S. Venture Partners
5.64M
21.22%
+5.64M
--
Jul 24, 2025
OrbiMed Advisors, LLC
1.25M
4.71%
+400.74K
+47.04%
Sep 30, 2025
Cordonnier (Michael)
1.24M
4.66%
+1.24M
--
Jul 24, 2025
Janus Henderson Investors
1.09M
4.11%
+1.09M
--
Sep 30, 2025
Casey (Niall)
941.20K
3.54%
+941.20K
--
Jul 24, 2025
Root (Jonathan D)
484.00K
1.82%
+484.00K
--
Jul 24, 2025
BlackRock Institutional Trust Company, N.A.
355.10K
1.34%
+355.10K
--
Sep 30, 2025
Avidity Partners Management LP
321.91K
1.21%
+321.91K
--
Sep 30, 2025
The Vanguard Group, Inc.
227.19K
0.85%
+115.83K
+104.01%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.02%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Carlsmed Ord Shs?
The top five shareholders of Carlsmed Ord Shs are:
B Capital Group Management LP holds 8.32M shares, accounting for 31.29% of the total shares.
U.S. Venture Partners holds 5.64M shares, accounting for 21.22% of the total shares.
OrbiMed Advisors, LLC holds 1.25M shares, accounting for 4.71% of the total shares.
Cordonnier (Michael) holds 1.24M shares, accounting for 4.66% of the total shares.
Janus Henderson Investors holds 1.09M shares, accounting for 4.11% of the total shares.
B Capital Group Management LP holds 8.32M shares, accounting for 31.29% of the total shares.
U.S. Venture Partners holds 5.64M shares, accounting for 21.22% of the total shares.
OrbiMed Advisors, LLC holds 1.25M shares, accounting for 4.71% of the total shares.
Cordonnier (Michael) holds 1.24M shares, accounting for 4.66% of the total shares.
Janus Henderson Investors holds 1.09M shares, accounting for 4.11% of the total shares.
What are the top three shareholder types of Carlsmed Ord Shs?
The top three shareholder types of Carlsmed Ord Shs are:
B Capital Group Management LP
U.S. Venture Partners
OrbiMed Advisors, LLC
B Capital Group Management LP
U.S. Venture Partners
OrbiMed Advisors, LLC
How many institutions hold shares of Carlsmed Ord Shs (CARL)?
As of 2025Q4, 68 institutions hold shares of Carlsmed Ord Shs, with a combined market value of approximately 10.32M, accounting for 38.80% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.00%.
What is the biggest source of revenue for Carlsmed Ord Shs?
In --, the -- business generated the highest revenue for Carlsmed Ord Shs, amounting to -- and accounting for --% of total revenue.
